Prevalence of methylenetetrahydrofolate reductase 677T and 1298C alleles and folate status: A comparative study in Mexican, West African, and European populations

American Journal of Clinical Nutrition

Volumn 83, Issue 3, 2006, Pages 701-707

  Guéant Rodriguez, Rosa Maria ^a   Guéant, Jean Louis ^a   Debard, Renée ^a   Thirion, Sylvie ^a   Lu, Xiao Hong ^a   Bronowicki, Jean Pierre ^a   Namour, Farès ^a   Chabi, Nicodème W ^b   Sanni, Ambaliou ^b   Anello, Guido ^c   Bosco, Paolo ^c   Romano, Corrado ^c   Amouzou, Emile ^d   Arrieta, Heidy R ^e   Sánchez, Beatríz E ^e   Romano, Antonino ^f   Herbeth, Bernard ^a   Guilland, Jean Claude ^g   Mutchinick, Osvaldo M ^e  

^a INSERM   (France)

^b Laboratory of Biochemistry and Nutrition   (Togo)

^c OASI RESEARCH INSTITUTE IRCCS   (Italy)

^d Department of Dermatology and Venerology   (Benin)

^e INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^f CATHOLIC UNIVERSITY   (Italy)

^g UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

Folate; Homocysteine; Methylenetetrahydrofolate reductase; Polymorphism; Vitamin B 12

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; FOLIC ACID; GENOMIC DNA; HOMOCYSTEINE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ADULT; AFRICA; ALLELE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; EUROPE; FOLIC ACID BLOOD LEVEL; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN EXPERIMENT; MEXICO; MULTIPLE REGRESSION; NORMAL HUMAN; POPULATION RESEARCH; PREVALENCE; PROTEIN BLOOD LEVEL; UNIVARIATE ANALYSIS; VITAMIN BLOOD LEVEL; ADOLESCENT; BLOOD; FEMALE; GENETICS; MALE; MIDDLE AGED; REGRESSION ANALYSIS;

ADOLESCENT; ADULT; AFRICA, WESTERN; ALLELES; EUROPE; FEMALE; FOLIC ACID; GENE FREQUENCY; GENOTYPE; HOMOCYSTEINE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MEXICO; MIDDLE AGED; POLYMORPHISM, GENETIC; REGRESSION ANALYSIS; VITAMIN B 12;

EID: 33645652119     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn.83.3.701     Document Type: Article

References (60)

1. Bollander-Gouaille C. Focus on homocysteine and the vitamins involved in its metabolism. 2nd ed. Paris, France: Springer-Verlag, 2002.
2. Ueland PM, Hustad S, Schneede J, et al. Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol Sci 2001;22:195-201.
3. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-3.
4. Friso S, Choi SW, Girelli D, et al. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction in the folate status. Proc Natl Acad Sci U S A 2002;99:5606-11.
5. van der Put NM, Gabreels F, Stevens EM, et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 1998;62:1044-51.
6. Rosenberg N, Murata M, Ikeda Y, et al. The frequent 5,10- methylenetetrahydrofolate reductase C677T polymorphism is associated with a common haplotype in whites, Japanese, and Africans. Am J Hum Genet 2002;70:758-62.
7. Mutchinick OM, Lopez MA, Luna L, Waxman J, Babinsky VE. High prevalence of the thermolabile methylenetetrahydrofolate reductase variant in Mexico: a country with a very high prevalence of neural tube defects. Mol Genet Metabol 1999;68:461-7.
8. Amouzou EK, Chabi NW, Adjalla CE, et al. High prevalence of hyperhomocysteinemia related to folate deficiency and the 677C→T mutation of the gene encoding methylenetetrahydrofolate reductase in coastal West Africa. Am J Clin Nutr 2004;79:619-24.
9. Ubbink JB, Christianson A, Bester MJ, et al. Folate status, homocysteine metabolism, and methylene tetrahydrofolate reductase genotype in rural South African blacks with a history of pregnancy complicated by neural tube defects. Metabolism 1999;48:269-74.
10. Rajkovic A, Mahomed K, Rozen R, Malinow MR, King IB, Williams MA. Methylenetetrahydrofolate reductase 677 C→T polymorphism, plasma folate, vitamin B(12) concentrations, and risk of preeclampsia among black African women from Zimbabwe. Mol Genet Metabol 2000;69:33-9.
11. Wilcken B, Bamforth F, Li Z, et al. Geographical and ethnic variation of the 677C→T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas world wide. J Med Genet 2003;40:619-25.
12. Pepe G, Camacho Vanegas O, Giusti B, et al. Heterogeneity in world distribution of the thermolabile C677T mutation in 5,10- methylenetetrahydrofolate reductase. Am J Hum Genet 1998;63:917-20.
13. Bosco P, Guéant-Rodriguez RM, Anello G, et al. In Sicily, methionine synthase (MTR) 2756 (A→G) polymorphism, double heterozygosity methionine synthase 2756 AG/methionine synthase reductase (MTRR) 66 AG and elevated homocysteinemia are three risk factors for having a child with Down syndrome. Am J Med Genet 2003;121:219-24.
14. Zetterberg H. Methylenetetrahydrofolate reductase and transcobalamin genetic polymorphisms in human spontaneous abortion: biological and clinical implications. Reprod Biol Endocrinol 2004;2:7.
15. de Bree A, Verschuren WM, Blom HJ, Kromhout D. Association between B vitamin intake and plasma homocysteine concentration in the general Dutch population aged 20-65 y. Am J Clin Nutr 2001;73:1027-33.
16. Mennen LI, de Courcy GP, Guilland JC, et al. Homocysteine, cardiovascular disease risk factors, and habitual diet in the French Supplementation with Antioxidant Vitamins and Minerals Study. Am J Clin Nutr 2002;76:1279-89.
17. Kushi LH, Lenart EB, Willett WC: Health implications of Mediterranean diets in light of contemporary knowledge. 1. Plant foods and dairy products. Am J Clin Nutr 1995;61(suppl):1407S-15S.
18. Turrini A, Saba A, Perrone D, Cialfa E, D'Amicis A. Food consumption patterns in Italy: the INN-CA Study 1994-1996. Eur J Clin Nutr 2001;55:571-88.
19. Panza F, D'Introno A, Colacicco AM, et al. Vascular genetic factors and human longevity. Mech Ageing Dev 2004;125:169-78.
20. Cavantes EI, Mutchinick OM. Defectos de cierre del tubo neural y nutrición materna: estudio multicéntrico en una muestra de la boblación Mexicana. (Neural tube defects and maternal nutrition. Multicentric study in a Mexican population.) Doctoral dissertation. National Autonomous University of Mexico, Mexico City, Mexico, 1999 (in Spanish).
21. Allen LH. Folate and vitamin B12 status in the Americas. Nutr Rev 2004;62:S29-33.
22. Quinlivan EP, McPartlin J, McNulty H, et al. Importance of both folic acid and vitamin B12 in reduction of risk of vascular disease. Lancet 2002;359:227-8.
23. Munoz-Moran E, Dieguez-Lucena JL, Fernandez-Arcas N, Peran-Mesa S, Reyes-Engel A. Genetic selection and folic acid intake during pregnancy. Lancet 1998;352:1120-1.
24. Isolato PA, Wells GA, Donnelly JG. Neonatal and fetal methylenetetrahydrofolate reductase genetic polymorphisms: an examination of C677T and A1298C mutations. Am J Hum Genet 2000;67:986-90.
25. Zetterberg H, Regland B, Palmér M, et al. Increased frequency of combined methylenetetrahydrofolate reductase C677T and A1298C mutated alleles in spontaneously aborted embryos. Eur J Hum Genet 2002;10:113-8.
26. van der Put NM, Steegers-Theunissen RP, Frosst P, et al. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 1995;346:1070-1.
27. James SJ, Pogribna M, Pogribny IP, et al. Abnormal folate metabolism and methylenetetrahydrofolate reductase (MTHFR) gene may be maternal risk factors for Down syndrome. Am J Clin Nutr 1999;70:495-501.
28. Nelen WL, Steegers EA, Eskes TK, Blom HJ. Genetic risk factor for unexplained recurrent early pregnancy loss. Lancet 1997;350:861 (letter).
29. Lissak A, Sharon A, Fruchter O, Kassel A, Sanderovitz J, Abramovici H. Polymorphism for mutation of cytosine to thymine at location 677 in the methylenetetrahydrofolate reductase gene is associated with recurrent early fetal loss. Am J Obstet Gynecol 1999;181:126-30.
30. Gueant JL, Candito M, Andres E, Van Obberghen E, Nicolas JP. Familial pernicious anaemia with hyperhomocysteinaemia in recurrent early pregnancy loss. Thromb Haemost 2004;92:1147-9.
31. Kumar KS, Govindaiah V, Naushad SE, Devi RR, Jyothy A. Plasma homocysteine levels correlated to interactions between folate status and methylene tetrahydrofolate reductase gene mutation in women with unexplained recurrent pregnancy loss. J Obstet Gynaecol 2003;23:55-8.
32. Guéant JL, Guéant-Rodriguez RM, Anello G, et al. Genetic determinants of folate and vitamin B12 metabolism: a common pathway in neural tube defect and Down syndrome? Clin Chem Lab Med 2003;41:1473-7.
33. de Franchis R, Sebastio G, Andria G, Mastroiacovo P. Spina bifida, 677TT mutation, and role of folate. Lancet 1995;346:1703 (letter).
34. Papapetrou C, Lynch SA, Burn J, Edwards YH. Methylenetetrahydrofolate reductase and neural tube defects. Lancet 1996;348:58 (letter).
35. de Franchis R, Buoninconti A, Mandato C, et al. The C677T mutation of the 5,10-methylenetetrahydrofolate reductase gene is a moderate risk factor for spina bifida in Italy. J Med Genet 1998;35:1009-13.
36. Guéant-Rodriguez RM, Rendeli C, Namour B, et al. Transcobalamin and methionine synthase reductase mutated polymorphisms aggravate the risk of neural tube defects. Neurosci Lett 2003;344:189-92.
37. Stegman K, Ziegler A, Ngo ET, et al. Linkage disequilibrium of MTHFR genotypes 677C/T-1298A/C in the German population and association studies in probands with neural tube defects (NTD). Am J Med Genet 1999;87:23-9.
38. Whitehead AS, Gallagher P, Mills JL, et al. A genetic defect in 5,10-methylenetetrahydrofolate reductase in neural tube defects. QJM 1995;88:763-6.
39. Christensen B, Arbour L, Tran P, et al. Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects. Am J Med Genet 1999;84:151-7.
40. Shields DC, Kirke PN, Mills JL, et al. The "thermolabile" variant of methylenetetrahydrofolate reductase and neural tube defects: an evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. Am J Hum Genet 1999;64:1045-55
41. Hobbs CA, Sherman SL, Yi P, et al. Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down syndrome. Am J Hum Genet 2000;67:623-30.
42. Rosenblatt DS. Folate and homocysteine metabolism and gene polymorphisms in the etiology of Down syndrome. Am J Clin Nutr 1999;70:429-30.
43. Hassold TJ, Burrage LC, Chan ER, et al. Maternal folate polymorphisms and the etiology of human nondisjunction. Am J Hum Genet 2001;69:434-9.
44. O'Leary VB, Parle-McDermott AP, Molloy AM, et al. MTRR and MTHFR polymorphisms: link to Down syndrome? Am J Med Genet 2002;107:151-5.
45. Stuppia L, Gatta V, Gaspari AR, et al. C677T mutation in the 5,10-MTHFR gene and risk of Down syndrome in Italy. Eur J Hum Genet 2002;10:388-90.
46. Chadefaux-Vekemans B, Coude M, Muller F, Oury J, Cali A, Kamoun P. Methylenetetrahydrofolate reductase polymorphisms in the etiology of Down syndrome. Pediatr Res 2002;51:766-7.
47. Boduroglu K, Alanay Y, Koldan B, Tuncbilek E. Methylenetetrahydrofolate reductase enzyme polymorphisms as maternal risk for Down syndrome among Turkish women. Am J Med Genet A 2004;127:5-10.
48. Zetterberg H, Regland B, Palmér M, et al. The transcobalamin codon 259 polymorphism influences the risk of human spontaneous abortion. Hum Reprod 2002;17:3033-6.
49. Zetterberg H, Zafiropoulos A, Spandidos DA, Rymo L, Blennow K. Gene-gene interaction between fetal MTHFR 677C→T and transcobalamin 776C>G polymorphisms in human spontaneous abortion. Hum Reprod 2003;18:1948-50.
50. Namour F, Olivier J, Abdelmouttaleb I, et al. Transcobalamin codon 259 polymorphism in HT-29 and Caco-2 cells and in Caucasians: relation to transcobalamin and homocysteine concentration in blood. Blood 2001;97:1092-8.
51. Blount BC, Mack MM, Wehr CM, et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci U S A 1997;94:3290-5.
52. Kapiszewska M, Kalemba M, Wojciech U, Milewicz T. Uracil misincorporation into DNA of leukocytes of young women with positive folate balance depends on plasma vitamin B-12 concentrations and methylenetetrahydrofolate reductase polymorphisms. A pilot study. J Nutr Biochem 2005;8:467-78.
53. Ingrosso D, Cimmino A, Perna AF, et al. Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia. Lancet 2003;361:1693-9.
54. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Gen Metab 1998;64:169-72.
55. Weisberg IS, Jacques PF, Selhub J, et al. The 1298A→C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine. Atherosclerosis 2001;156:409-15.
56. Lachmeijer AM, Arngrimsson R, Bastiaans EJ, et al. Mutations in the gene for methylenetetrahydrofolate reductase, homocysteine levels, and vitamin status in women with a history of preeclampsia. Am J Obstet Gynecol 2001;184:394-402.
57. Aldamiz-Echevarria L, Sanjurjo P, Vallo A, et al. Hyperhomocysteinemia in children with renal transplants. Pediatr Nephrol 2002;17:718-23.
58. Akar N, Akar E, Ozel D, Deda G, Sipahi T. Common mutations at the homocysteine metabolism pathway and pediatric stroke. Thromb Res 2001;102:115-20.
59. Guéant-Rodriguez RM, Juillière Y, Candito M, et al. Association of MTRR A66G polymorphism (but not of MTHFR C677T and A1298C, MTR A2756G, TCN C776G) with homocysteine and coronary artery disease in the French population. Thromb Haemost 2005;94:510-5.
60. Yamada K, Chen Z, Rozen R, Matthews RG. Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase. Proc Natl Acad Sci U S A 2001;26:14853-8.